Company news
Zelira Therapeutics Ltd. news in 2018
Zelira Therapeutics Ltd.'s news releases, calls and decks from 2018, newest first.
ZLD to Invest in Development of Oral Spray Formulations
December 5, 2018
Opioid reduction clinical trial with St Vincents Hospital
November 25, 2018
September 2018 Quarterly Report
October 31, 2018
Zelda Focuses Clinical Trial Activity
October 10, 2018
US Autism Observational Study Underway
October 9, 2018
First Patient Dosed in Zelda Insomnia Trial
September 25, 2018
Zelda Forms New Partnership to Access German Market
September 3, 2018
June 2018 Quarterly Report
July 29, 2018
Commencement of New Managing Director
July 15, 2018
Appointment of Managing Director
May 21, 2018
March 2018 Quarterly Report
April 29, 2018
Insomnia Clinical Trial Update-Patient Recruitment Completed
April 22, 2018
Expansion of Pancreatic Cancer Research Programme
March 5, 2018
Appendix 4D & FY18 Interim Financial Report
February 27, 2018
Decks in 2018
- Zelda Therapeutics — Shareholder Meeting (November 2018)
Shareholder meeting · 25 slides · Nov 30, 2018
- Zelda Therapeutics — Investor Presentation (September 2018)
Investor deck · 27 slides · Sep 25, 2018